TEMPERATURE, FOOD-INTAKE, AND LOCOMOTOR-ACTIVITY EFFECTS OF A 5-HT3 RECEPTOR AGONIST AND 2 5-HT3 RECEPTOR ANTAGONISTS IN RATS

被引:31
作者
MAZZOLAPOMIETTO, P
AULAKH, CS
MURPHY, DL
机构
[1] Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, 20892, Maryland, Bldg. 10
关键词
1-M-CHLOROPHENYLBIGUANIDE; MDL-72222; ONDANSETRON; TEMPERATURE; FOOD INTAKE; LOCOMOTOR ACTIVITY;
D O I
10.1007/BF02246499
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study investigated three physiologic functions known to be modulated by serotonin - temper ature, food intake and locomotor activity - using the 5-HT3 receptor agonist, m-chlorophenylbiguanide (m-CPBG), and two 5-HT3 antagonists, MDL-72222 and ondansetron. m-CPBG produced dose-dependent elevations in rectal temperature. MDL-72222, which had no effects on temperature when given alone, significantly attenuated m-CPBG-induced hyperthermia. Food intake in food-deprived rats was reduced during the first hour by the highest dose of m-CPBG. Food intake was also dose-dependently reduced by MDL-72222; m-CPBG plus MDL-72222 led to greater reductions in food intake. Food intake in freely fed rats was unaffected by m-CPBG or MDL-72222. Locomotor activity was unaffected by m-CPBG, but was dose-dependently reduced by MDL-72222, an effect which may have contributed to its hypophagic effects. Ondansetron, used in ten-fold lower doses than MDL-72222, was inactive in all of these paradigms. These data: (1) provide some evidence for 5-HT3 receptor-mediated changes in temperature; (2) are in agreement with two prior studies which reported locomotor activity reductions following 5-HT3 antagonists; but (3) do nor support an important role for 5-HT, receptors in the regulation of food intake in rats.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 48 条
[1]   CENTRAL ACTION OF 5-HT(3) RECEPTOR LIGANDS IN THE REGULATION OF SLEEP WAKEFULNESS AND RAPHE NEURONAL-ACTIVITY IN THE RAT [J].
ADRIEN, J ;
TISSIER, MH ;
LANFUMEY, L ;
HAJDAHMANE, S ;
JOLAS, T ;
FRANC, B ;
HAMON, M .
NEUROPHARMACOLOGY, 1992, 31 (06) :519-529
[2]   EVIDENCE FOR CENTRAL AND PERIPHERAL SEROTONERGIC CONTROL OF CORTICOSTERONE SECRETION IN THE CONSCIOUS RAT [J].
ALPER, RH .
NEUROENDOCRINOLOGY, 1990, 51 (03) :255-260
[3]  
Aulakh C. S., 1989, PHARM BIOCH BEHAV, V31, P567
[4]  
AULAKH CS, 1992, J PHARMACOL EXP THER, V263, P588
[5]  
AULAKH CS, 1994, J PHARMACOL EXP THER, V270, P127
[6]   SEROTONIN AGONISTS CAUSE PARALLEL ACTIVATION OF THE SYMPATHOADRENOMEDULLARY SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL AXIS IN CONSCIOUS RATS [J].
BAGDY, G ;
CALOGERO, AE ;
MURPHY, DL ;
SZEMEREDI, K .
ENDOCRINOLOGY, 1989, 125 (05) :2664-2669
[7]   5-HT3 RECEPTORS MEDIATE INHIBITION OF ACETYLCHOLINE-RELEASE IN CORTICAL TISSUE [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ ;
TYERS, MB .
NATURE, 1989, 338 (6218) :762-763
[8]   ACTIVATION OF A 5-HT3 RECEPTOR RELEASES DOPAMINE FROM RAT STRIATAL SLICE [J].
BLANDINA, P ;
GOLDFARB, J ;
GREEN, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) :349-350
[9]   PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS [J].
BUTLER, A ;
HILL, JM ;
IRELAND, SJ ;
JORDAN, CC ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :397-412
[10]   MECHANISMS OF SEROTONIN RECEPTOR AGONIST-INDUCED ACTIVATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN THE RAT [J].
CALOGERO, AE ;
BAGDY, G ;
SZEMEREDI, K ;
TARTAGLIA, ME ;
GOLD, PW ;
CHROUSOS, GP .
ENDOCRINOLOGY, 1990, 126 (04) :1888-1894